BDNF-Met polymorphism and amyloid-beta in relation to cognitive decline in cognitively normal elderly: the SCIENCe project

Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

(2021) Itziar de Rojas et al.   Nature Communications

The characterisation of subjective cognitive decline

(2020) Frank Jessen et al.   LANCET NEUROLOGY

The BDNF Val66Met Polymorphism Modulates Resilience of Neurological Functioning to Brain Ageing and Dementia: A Narrative Review

(2020) Donnamay T. Brown et al.   Brain Sciences

Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk

(2019) Iris E. Jansen et al.   NATURE GENETICS

Impact of APOE and BDNF Val66Met Gene Polymorphisms on Cognitive Functions in Patients with Amnestic Mild Cognitive Impairment

(2019) Katerina Cechova et al.   JOURNAL OF ALZHEIMERS DISEASE

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Amsterdam Dementia Cohort: Performing Research to Optimize Care

(2018) Wiesje M. van der Flier et al.   JOURNAL OF ALZHEIMERS DISEASE

Thinner cortex in patients with subjective cognitive decline is associated with steeper decline of memory

(2018) Sander C.J. Verfaillie et al.   NEUROBIOLOGY OF AGING

Optimizing Patient Care and Research: The Amsterdam Dementia Cohort

(2018) Wiesje M. van der Flier et al.   JOURNAL OF ALZHEIMERS DISEASE

Physical Exercise Improves Peripheral BDNF Levels and Cognitive Functions in Mild Cognitive Impairment Elderly with Different BDNF Val66Met Genotypes

(2018) Carla Manuela Crispim Nascimento et al.   JOURNAL OF ALZHEIMERS DISEASE

Subjective Cognitive Impairment Cohort (SCIENCe): study design and first results

(2018) Rosalinde E. R. Slot et al.   Alzheimers Research & Therapy

Subjective cognitive decline and rates of incident Alzheimer's disease and non–Alzheimer's disease dementia

(2018) Rosalinde E.R. Slot et al.   Alzheimers & Dementia

BDNF Val66Met in preclinical Alzheimer's disease is associated with short-term changes in episodic memory and hippocampal volume but not serum mBDNF

(2017) Yen Ying Lim et al.   INTERNATIONAL PSYCHOGERIATRICS

Circadian Rhythms in Plasma Brain-derived Neurotrophic Factor Differ in Men and Women

(2017) Sean W. Cain et al.   JOURNAL OF BIOLOGICAL RHYTHMS

BDNF Val66Met predicts cognitive decline in the Wisconsin Registry for Alzheimer's Prevention

(2017) Elizabeth A. Boots et al.   NEUROLOGY

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

BDNFVal66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer’s disease

(2016) Yen Ying Lim et al.   BRAIN

Alzheimer's disease

(2016) Philip Scheltens et al.   LANCET

A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease

(2014) Frank Jessen et al.   Alzheimers & Dementia

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer’s disease

(2014) Y Y Lim et al.   MOLECULAR PSYCHIATRY

The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease

(2014) Tara L. Spires-Jones et al.   NEURON

Effect of BDNF Val66Met on Memory Decline and Hippocampal Atrophy in Prodromal Alzheimer’s Disease: A Preliminary Study

(2014) Yen Ying Lim et al.   PLoS One

BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases

(2013) Bai Lu et al.   NATURE REVIEWS NEUROSCIENCE

BDNF Val66Met, Aβ amyloid, and cognitive decline in preclinical Alzheimer's disease

(2013) Yen Ying Lim et al.   NEUROBIOLOGY OF AGING

Preclinical AD predicts decline in memory and executive functions in subjective complaints

(2013) A. C. van Harten et al.   NEUROLOGY

Cerebrospinal fluid Aβ42 is the best predictor of clinical progression in patients with subjective complaints

(2012) Argonde C. van Harten et al.   Alzheimers & Dementia

Plasma BDNF Is Associated with Age-Related White Matter Atrophy but Not with Cognitive Function in Older, Non-Demented Adults

(2012) Ira Driscoll et al.   PLoS One

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

(2011) Katya Rascovsky et al.   BRAIN

The Neurotrophins and Their Role in Alzheimers Disease

(2011) Shelley J. Allen et al.   Current Neuropharmacology

Classification of primary progressive aphasia and its variants

(2011) M. L. Gorno-Tempini et al.   NEUROLOGY

Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function

(2010) Antonio Lucio Teixeira et al.   Biomarkers in Medicine

Circulating Brain-Derived Neurotrophic Factor and Indices of Metabolic and Cardiovascular Health: Data from the Baltimore Longitudinal Study of Aging

(2010) Erin Golden et al.   PLoS One

Amyloid- (1-42), Total Tau, and Phosphorylated Tau as Cerebrospinal Fluid Biomarkers for the Diagnosis of Alzheimer Disease

(2009) C. Mulder et al.   CLINICAL CHEMISTRY

TrkB signalling pathways in LTP and learning

(2009) Liliana Minichiello   NATURE REVIEWS NEUROSCIENCE

A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression

(2008) André Russowsky Brunoni et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Serum Brain-Derived Neurotrophic Factor Is Associated With Cognitive Function in Healthy Older Adults

(2008) John Gunstad et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Brain-derived neurotrophic factor polymorphism Val66Met influences cognitive abilities in the elderly

(2007) F. Miyajima et al.   GENES BRAIN AND BEHAVIOR